Local botulinum toxin a for treating chronic sialorrhea;Lokale Botulinumtoxin-a-therapie bei Chronischer Sialorrhö

HNO

Volumn 56, Issue 9, 2008, Pages 941-946

  Krause, E ^a   Botzel K ^a   De La Chaux, R ^a   Gurkov R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dysphagia; Hypersalivation; Injection; Salivary glands; Ultrasound

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; HYPERSALIVATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SIALORRHEA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51649127940     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-008-1820-0     Document Type: Article

References (19)

1. Breuer T, Ferrazzini A, Grossenbacher R (2006) Botulinumtoxin A zur Therapie traumatischer Speichelfisteln. HNO 54: 385-390, 392-393
2. Bushara KO (1997) Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands. Med Hypotheses 48: 337-339
3. Ellies M, Gottstein U, Rohrbach-Volland S et al. (2004) Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114: 1856-1860
4. Ellies M, Laskawi R, Götz W et al. (1999) Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat. Eur Arch Otorhinolaryngol 256: 148-152
5. Ellies M, Laskawi R, Rohrbach-Volland S et al. (2001) Sekretionshemmung exokriner Drüsen des Kopf-Hals-Bereiches durch Applikation von Botulinum Toxin A. HNO 49: 807-813
6. Erbguth FJ (1998) Botulinum toxin, a historical note. Lancet 351: 1820
7. Guntinas-Lichius O, Eckel HE (2002) Temporary reduction of salivation in laryngectomy patients with pharyngocutaneous fistulas by botulinum toxin A injection. Laryngoscope 112: 187-189
8. Guntinas-Lichius O, Jungehülsing M. (2002) Treatment of chronic parotid sialectasis with botulinum toxin A. Laryngoscope 112: 586-587
9. Guntinas-Lichius O, Sittel C (2001) Treatment of postparotidectomy salivary fistula with botulinum toxin. Ann Otol Rhinol Laryngol 110: 1162-1164
10. Jongerius PH, Rotteveel JJ, van Limbeek J et al. (2004) Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63: 1371-1375
11. Lagalla G, Millevolte M, Capecci M et al. (2006) Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21: 704-707
12. Lim M, Mace A, Nouraei SA et al. (2006) Botulinum toxin in the management of sialorrhoea: a systematic review. Clin Otolaryngol 31: 267-272
13. Lipp A, Trottenberg T, Schink T et al. (2003) A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61: 1279-1281
14. Mancini F, Zangaglia R, Cristina S et al. (2003) Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18: 685-688
15. Marina MB, Sani A, Hamzaini AH et al. (2007) Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling. J Laryngol Otol 1-6
16. Ondo WG, Hunter C, Moore W (2004) A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 62: 37-40
17. Rapp D (1980) Drool control: long-term follow-up. Dev Med Child Neurol 22: 448-453
18. Savarese R, Diamond M, Elovic E et al. (2004) Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil 83: 304-311
19. Suskind DL, Tilton A (2002) Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112: 73-81